Skip to main content
BBNX
NASDAQ Industrial Applications And Services

Beta Bionics Upsizes Public Offering to $150M, Adds Pre-Funded Warrants

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Medical Device Stocks · Healthcare
Sentiment info
Neutral
Importance info
7
Price
$22.15
Mkt Cap
$997.871M
52W Low
$8.8
52W High
$32.71
52W Position info
152% above low
Off High info
32% below high
Rel. Volume info
5.7× avg
Market data snapshot near publication time

BBNX has more than doubled off its 52-week low of $8.8 on elevated volume (5.7× avg).

Summary

Beta Bionics upsized its public offering to $150M gross proceeds, adding pre-funded warrants and locking in underwriting terms with J.P. Morgan, Piper Sandler, Wells Fargo, and Leerink.


Key Events · Financing and Capital Events · BBNX

  • Offering Upsized to $150M

    Gross proceeds increased to approximately $150.0 million from the originally announced $125.0 million, reflecting strong demand.

  • Pre-Funded Warrants Added

    1,043,484 pre-funded warrants at $17.2499 each (exercise price $0.0001) were added to the offering, creating a dilutive overhang when exercised.

  • Underwriting Terms Set

    Underwriting discounts and commissions are $1.035 per share/warrant; J.P. Morgan, Piper Sandler, Wells Fargo, and Leerink are joint book-running managers.

  • Closing Expected September 17

    The offering is expected to close on September 17, 2026, subject to customary closing conditions.


Analysis · BBNX · Industrial Applications And Services

Beta Bionics formalized its underwritten public offering, upsizing gross proceeds to approximately $150 million from the originally announced $125 million. The deal includes 7,652,175 common shares at $17.25 and pre-funded warrants for 1,043,484 shares at $17.2499, with a 30-day option for 1,304,348 additional shares. Underwriting discounts are $1.035 per share/warrant, and the offering is expected to close September 17, 2026. The capital funds Mint commercialization, manufacturing expansion, and R&D. The pre-funded warrants add a dilutive overhang, but the upsized proceeds strengthen the balance sheet for the commercial launch.

How filings like this one have moved

In the 30 days to Nov 2, 2026, 32.7% of the 1910 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was 0.00%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, BBNX was trading at $22.15 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $997.9M. The 52-week trading range was $8.80 to $32.71. This filing was assessed with neutral market sentiment and an importance score of 7 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

BBNX - Latest Insights

BBNX
Oct 27, 2026, 4:20 PM EDT
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $18.92
Real-time Price: $16.04 info
Change: -$2.88 (-15%) info
Market Cap: $872.048M info
BBNX
Oct 27, 2026, 4:04 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $20.89
Real-time Price: $16.04 info
Change: -$4.85 (-23%) info
Market Cap: $872.048M info
BBNX
Oct 27, 2026, 4:02 PM EDT
Source: GlobeNewswire
Importance Score:
8
Price at Filing: $21.01
Real-time Price: $16.04 info
Change: -$4.97 (-24%) info
Market Cap: $872.048M info
BBNX
Oct 06, 2026, 5:36 AM EDT
Source: PR Newswire
Importance Score:
9
Price at Filing: $18.95
Real-time Price: $16.04 info
Change: -$2.91 (-15%) info
Market Cap: $872.048M info
BBNX
Sep 22, 2026, 7:30 AM EDT
Source: GlobeNewswire
Importance Score:
7
Price at Filing: $22.19
Real-time Price: $16.04 info
Change: -$6.15 (-28%) info
Market Cap: $872.048M info